Synthesis, spectroscopic characterization and structural investigations of a new charge transfer complex of 2,6-diaminopyridine with 3,5-dinitrobenzoic acid: DNA binding and antimicrobial studies
A new charge transfer (CT) complex [(DAPH) + (DNB) - ] consisting of 2,6-diaminopyridine (DAP) as donor and 3,5-dinitrobenzoic acid (DNB-H) as acceptor, was synthesized and characterized by FTIR, 1 H and 13 C NMR, ESI mass spectroscopic and X-ray crystallographic techniques. The hydrogen bonding (N...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | JOUR |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_00222860_v1035_n_p38_Khan |
Aporte de: |
Sumario: | A new charge transfer (CT) complex [(DAPH) + (DNB) - ] consisting of 2,6-diaminopyridine (DAP) as donor and 3,5-dinitrobenzoic acid (DNB-H) as acceptor, was synthesized and characterized by FTIR, 1 H and 13 C NMR, ESI mass spectroscopic and X-ray crystallographic techniques. The hydrogen bonding (N + -H⋯O - ) plays an important role to consolidate the cation and anion together. CT complex shows a considerable interaction with Calf thymus DNA. The CT complex was also tested for its antibacterial activity against two Gram-positive bacteria Staphylococcus aureus and Bacillus subtilis and two Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa strains by using Tetracycline as standard, and antifungal property against Aspergillus niger, Candida albicans, and Penicillium sp. by using Nystatin as standard. The results were compared with standard drugs and significant conclusions were obtained. A polymeric net work through H-bonding interactions between neighboring moieties was observed. This has been attributed to the formation of 1:1 type CT complex. © 2012 Elsevier B.V. All rights reserved. |
---|